Crossmark

Clinical features of glioma patients who develop pneumocystis pneumonia with temozolomide chemoradiotherapy

Published Online: 2022-08-06

Published Print: 2022-09

Authors

Climans, Seth A. https://orcid.org/0000-0002-4961-237X
Mason, Warren P.

Grunfeld, Eva

Chan, Kelvin
Funding

Funding for this research was provided by:

Canadian Cancer Society (2015-703549)
License Information

Text and Data Mining valid from 2022-08-06

Version of Record valid from 2022-08-06
More Information

Article History

Received: 25 May 2022

Accepted: 28 July 2022

First Online: 6 August 2022

Declarations

:

: The authors declare that we have no conflict of interest.

: The Research Ethics Board at Sunnybrook Health Sciences Centre confirmed that this project was exempt from review under Sect. 45 of Ontario’s Personal Health Information Protection Act. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.

: ICES is an independent, non-profit research institute whose legal status under Ontario’s health information privacy law allows it to collect and analyze health care and demographic data, without consent, for health system evaluation and improvement.

: Not applicable.

Document is current